Company profile
SeaStar Medical Holding Corporation
NASDAQ: ICU · Healthcare · Biotechnology
#858 of 1,422 Healthcare companies by revenuetop-decile growth
EA Score
30DFH 34DQ 23GM —SS 34
v0.1 · 55/100 weight · provisional
↑ revenue growth (YoY), balance-sheet leverage · ↓ disclosure history, listing tenure
Methodology →Revenue TTM
$1.7M
Rev growth YoY (TTM)
+123.6%
Net income (FY)
-$12.2M
Employees
17
as of 2026-08-22
Market cap
$9.5M
as of 2026-08-22
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$1.2M$1.2M2025
Net income-$12.2M-$12.2M2025
Operating income-$12.2M-$12.2M2025
Total assets$14.2M$14.2M2025
Liabilities$3.7M$3.7M2025
Equity$10.4M$10.4M2025
Revenue trend
FY2024 – FY2025 · USD
FY24
FY24
FY25
Revenue by segment
No segmentation disclosed for this filer. n/a
The read
What is SeaStar Medical Holding Corporation’s revenue?
SeaStar Medical Holding Corporation booked $1.2M in FY2025 revenue, growing 814% year over year — faster than 96% of Healthcare companies we track, at a -984.6% net margin.
Peers · Healthcare
Certive Solutions Inc.——VistaGen Therapeutics, Inc.46DBaudax Bio, Inc.——NRx Pharmaceuticals, Inc.24DLongeveron Inc.30DSOHM, Inc.61CNeighbors
Denver →Key facts
CEOEric Schlorff
SectorHealthcare
IndustryBiotechnology
HeadquartersDenver, CO
ExchangeNASDAQ: ICU
Employees17
IPO date2021-03-18
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.